Copyright
©The Author(s) 2025.
World J Gastroenterol. May 7, 2025; 31(17): 105438
Published online May 7, 2025. doi: 10.3748/wjg.v31.i17.105438
Published online May 7, 2025. doi: 10.3748/wjg.v31.i17.105438
Figure 4 Bicuculline may regulate lipid metabolism disorders in metabolic dysfunction-associated steatotic liver disease through the inflammatory response and metabolic reprogramming.
A and B: Volcano plot of differentially expressed genes in the control vs model and model vs bicuculline (BIC) groups; C: Venn diagram; D and E: Differential gene heatmap of the control vs model and model vs BIC groups; F: Gene Ontology enrichment analysis; G: Kyoto Encyclopedia of Genes and Genomes signaling pathway analysis. KEGG: Kyoto Encyclopedia of Genes and Genomes.
- Citation: Wang XM, Dai Z, Lu DJ, Bao CQ, Yang NB, Zhou YP. Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation. World J Gastroenterol 2025; 31(17): 105438
- URL: https://www.wjgnet.com/1007-9327/full/v31/i17/105438.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i17.105438